Literature DB >> 29545296

Draft Genome Sequences of Four Uropathogenic Escherichia coli Serotype O4:H5 Isolates (ATCC 700414, 700415, 700416, and 700417).

Aixia Xu1, Sarah Hertrich1, David S Needleman1, Shiowshuh Sheen1, Christopher Sommers2.   

Abstract

Uropathogenic Escherichia coli serotype O4:H5 isolates (ATCC 700414, 700415, 700416, and 700417) were recovered from women with first-time urinary tract infections. Here, we report the draft genome sequences for these four E. coli isolates, which are currently being used to validate food safety processing technologies.

Entities:  

Year:  2018        PMID: 29545296      PMCID: PMC5854768          DOI: 10.1128/genomeA.00134-18

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Uropathogenic Escherichia coli (UPEC) is responsible for 75% to 95% of the 10.5 million urinary tract infections (UTI) in the United States each year, which primarily affect women (1). UTI may be considered a form of foodborne illness, as UPEC is routinely found in food animals and retail food products (2) and food isolates have been shown to cause UTI in animal model systems (3). In addition, recent research has implicated UPEC in ulcerative colitis associated with inflammatory bowel disease (4). After consumption of UPEC-contaminated food by these patients, UPEC colonization of the distal gastrointestinal (GI) tract and integration of UPEC into GI ulcers can exacerbate the inflammatory response (4). The pathogenesis of UTI is due to accidental transfer of UPEC-contaminated feces from the GI tract to the urethra (1). The E. coli isolates associated with UTI are commonly a genetic match to those found in the individual’s feces (5). These four O4:H5 clinical UPEC isolates (6), obtained from women with first-time UTI, are currently being used to validate food safety intervention technologies along with other UPEC (7, 8). Genomic DNA was extracted using the DNeasy blood and tissue kit (Qiagen, Hilden, Germany) and quantified in a Qubit 3.0 fluorometer (Life Technologies, Carlsbad, CA, USA). The genomic DNA library was prepared using the Nextera DNA Flex library prep kit (Illumina, San Diego, CA, USA). Libraries were analyzed for concentration and then pooled and denatured for loading onto a flow cell for cluster generation. Denatured libraries were sequenced on an Illumina MiniSeq platform with a 2 × 150-bp read paired-end protocol with 30× coverage. Two Illumina reads from separate DNA preparations were assembled de novo using SPAdes (version 3.9.0). Virulence factors, antibiotic resistance genes, genome size, N50 values, multilocus sequence type (MLST), mRNA, rRNA, tRNA, genes, pseudogenes, and coding sequences (CDS) were determined using the Illumina Bacterial Analysis Pipeline (version 1.0.4) and the NCBI Prokaryotic Genome Annotation Pipeline (PGAP) (version 4.3). The accession numbers and assembly metrics are listed in Table 1.
TABLE 1

Accession numbers and assembly metrics of draft whole-genome sequences of four E. coli serotype O4:H5 isolates

ATCC isolate no.GenBank accession no.Genome size (bp)G+C content (%)BioProject no.
700414POSZ000000005,242,37250.47PRJNA429583
700415POTA000000005,300,80650.37PRJNA429606
700416POSX000000005,121,07250.36PRJNA429461
700417POSY000000005,336,84350.37PRJNA429467
Accession numbers and assembly metrics of draft whole-genome sequences of four E. coli serotype O4:H5 isolates Genomics data are now considered an integral part of risk assessment for food safety and environmental microbiology (9). These genomic data will be useful for understanding UPEC pathogenesis and should provide novel insights regarding the persistence of UPEC in foods and effective food safety practices for UPEC detection, control, and elimination.

Accession number(s).

The whole-genome shotgun projects reported here have been deposited in DDBJ/ENA/GenBank under the accession and BioProject numbers listed in Table 1. The versions described in this paper are the first versions.
  7 in total

Review 1.  Urinary tract infections: epidemiology, mechanisms of infection and treatment options.

Authors:  Ana L Flores-Mireles; Jennifer N Walker; Michael Caparon; Scott J Hultgren
Journal:  Nat Rev Microbiol       Date:  2015-04-08       Impact factor: 60.633

2.  Discovery of disseminated J96-like strains of uropathogenic Escherichia coli O4:H5 containing genes for both PapG(J96) (class I) and PrsG(J96) (class III) Gal(alpha1-4)Gal-binding adhesins.

Authors:  J R Johnson; T A Russo; F Scheutz; J J Brown; L Zhang; K Palin; C Rode; C Bloch; C F Marrs; B Foxman
Journal:  J Infect Dis       Date:  1997-04       Impact factor: 5.226

3.  Relationship between Escherichia coli strains causing acute cystitis in women and the fecal E. coli population of the host.

Authors:  Eva Moreno; Antonia Andreu; Carles Pigrau; Michael A Kuskowski; James R Johnson; Guillem Prats
Journal:  J Clin Microbiol       Date:  2008-05-21       Impact factor: 5.948

4.  Foodborne urinary tract infections: a new paradigm for antimicrobial-resistant foodborne illness.

Authors:  Lora Nordstrom; Cindy M Liu; Lance B Price
Journal:  Front Microbiol       Date:  2013-03-06       Impact factor: 5.640

5.  Inactivation of Uropathogenic Escherichia coli in Ground Chicken Meat Using High Pressure Processing and Gamma Radiation, and in Purge and Chicken Meat Surfaces by Ultraviolet Light.

Authors:  Christopher H Sommers; O J Scullen; Shiowshuh Sheen
Journal:  Front Microbiol       Date:  2016-04-14       Impact factor: 5.640

6.  Evaluation of Escherichia coli isolates from healthy chickens to determine their potential risk to poultry and human health.

Authors:  Zachary R Stromberg; James R Johnson; John M Fairbrother; Jacquelyn Kilbourne; Angelica Van Goor; Roy Curtiss; Melha Mellata
Journal:  PLoS One       Date:  2017-07-03       Impact factor: 3.240

7.  Extraintestinal pathogenic Escherichia coli are associated with intestinal inflammation in patients with ulcerative colitis.

Authors:  Hengameh C Mirsepasi-Lauridsen; Sofie Ingdam Halkjaer; Esben Munk Mortensen; Magnus C Lydolph; Inge Nordgaard-Lassen; Karen Angeliki Krogfelt; Andreas Munk Petersen
Journal:  Sci Rep       Date:  2016-09-30       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.